Graduate School of Medical Sciences News

Researchers at Weill Cornell Medicine have performed the most comprehensive analysis to date of cancer of the ureters or the urine-collection cavities in the kidney, known as upper tract urothelial carcinoma (UTUC). 

Important signaling molecules called phospholipids are active throughout cells in small compartments called condensates, rather than functioning primarily in cell membranes as previously thought, according to a study from researchers at Weill Cornell Medicine.

The Parker Institute for Cancer Immunotherapy (PICI) announced it has added Weill Cornell Medicine to its network of preeminent academic and medical research institutions at the forefront of the fight against cancer. 

The eleven students from the Weill Cornell Graduate School of Medical Sciences and the Gerstner Sloan Kettering Graduate School of Biomedical Sciences participated in the eighth annual Three-Minute Thesis (3MT®) competition, which challenged the young scientists to trim the scientific jargon and share their thesis projects creatively.

The institution is constructing a modern new student residence that, when it opens in 2025, will expand the scope of the institution’s Upper East Side campus and nearly double the existing student residential living space.

For the sixth consecutive year, Weill Cornell Medicine has been awarded the Health Professions Higher Education Excellence in Diversity (HEED) Award by INSIGHT Into Diversity magazine, which recognizes the institution’s exceptional commitment to diversity and inclusion.

Researchers at Weill Cornell Medicine have illuminated one of the important ways that cells respond to stress. The findings could also be relevant to Alzheimer’s, ALS and other diseases in which this mechanism may be abnormally active.

Weill Cornell Medicine has received a three-year, nearly $6 million grant to lead one of three national contraceptive research centers.

Dr. Gregory F. Sonnenberg, The Henry R. Erle, M.D.-Roberts Family Associate Professor of Medicine and head of basic research in Gastroenterology and Hepatology at Weill Cornell Medicine, has been awarded a $3.26 million, five-year MERIT grant from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, to investigate the underlying mechanisms of inflammatory bowel disease (IBD).

The $9.8 million, five-year grant awarded to Weill Cornell Medicine and Columbia University will help combat cancer disparities fueled by persistent poverty.

More than 350 expected graduates – 104 medical doctors, 86 with doctorates and 190 with Master of Science degrees – in the Class of 2023 received their degrees from Weill Cornell Medicine during the institution’s annual commencement ceremony at Carnegie Hall on May 18.

Dr. Cheryl Dreyfus, a distinguished professor and chair of the Department of Neuroscience and Cell Biology at Rutgers-Robert Wood Johnson Medical School, has been awarded the 2023 Weill Cornell Graduate School Alumni Award of Distinction.

Weill Cornell Graduate School of Medical Sciences honored students in the Class of 2023 for their academic achievements.

On May 5, Rubin was one of the 47 students in the Class of 2025 to receive their short white coats, gathered before an audience of faculty, family and friends at Griffis Faculty Club as part of the annual white coat ceremony.

In a celebration of Weill Cornell Medicine’s commitment to fostering inclusivity in academic medicine, the institution on April 25 honored nearly a dozen faculty, students and staff who exemplify excellence in diversity, equity and inclusion.

Dr. Matthew Greenblatt, an associate professor of pathology and laboratory medicine at Weill Cornell Medicine, has been awarded the Pershing Square Foundation’s Maximizing Innovation in Neuroscience Discovery (MIND) Prize to support his work studying how bone cells may influence Alzheimer’s disease progression.

Targeting part of an antiviral pathway triggered by the accumulation of a key pathogen shared in Alzheimer’s disease and frontotemporal dementia may one day offer a new therapeutic approach to deterring or delaying cognitive decline.

 The program's enduring goal during the past half century has been to create the next generation of leaders in biomedical research.

An experimental contraceptive drug candidate developed by Weill Cornell Medicine investigators temporarily stops sperm in their tracks and prevents pregnancies in preclinical models.

More than 160 faculty and students filled Uris Auditorium Dec. 5 to hear doctoral candidates deliver bite-size presentations of their research in an entertaining way. The catch? They had to deliver their work in three minutes or less.